Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 7/20 | 1.00 |
| ▸ | CYP1B1 | Q16678 | 7/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 6/20 | 1.00 |
| ▸ | MEN1 | O00255 | 6/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 6/20 | 1.00 |
| ▸ | MAPT | P10636 | 6/20 | 1.00 |
| ▸ | CYP1A1 | P04798 | 6/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | HPGD | P15428 | 5/20 | 1.00 |
| ▸ | FTO | Q9C0B1 | 5/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 5/20 | 1.00 |
| ▸ | POLH | Q9Y253 | 5/20 | 1.00 |
| ▸ | IP6K2 | Q9UHH9 | 5/20 | 1.00 |
| ▸ | TP53 | P04637 | 4/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 4/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 4/20 | 1.00 |
| ▸ | MAOA | P21397 | 4/20 | 1.00 |
| ▸ | MAOB | P27338 | 4/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 4/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Apigenin SCHEMBL29351464 | 1.00 | KMT2A (1.00) | KMT2ACYP1B1ABCB1MEN1CYP3A4 | |
| Apigenin SCHEMBL19428 | 1.00 | KMT2A (1.00) | KMT2ACYP1B1ABCB1MEN1CYP3A4 | |
| Apigenin SCHEMBL30544810 | 0.98 | KMT2A (0.97) | KMT2ACYP1B1ABCB1MEN1CYP3A4 | |
| Apigenin SCHEMBL29448148 | 0.98 | KMT2A (0.97) | KMT2ACYP1B1ABCB1MEN1CYP3A4 | |
| Apigenin SCHEMBL29968480 | 0.98 | KMT2A (0.97) | KMT2ACYP1B1ABCB1MEN1CYP3A4 | |
| Apigenin SCHEMBL1658882 | 0.98 | KMT2A (0.97) | KMT2ACYP1B1ABCB1MEN1CYP3A4 | |
| Apigenin SCHEMBL31168790 | 0.98 | KMT2A (0.97) | KMT2ACYP1B1ABCB1MEN1CYP3A4 | |
| Apigenin SCHEMBL31477961 | 0.98 | KMT2A (0.97) | KMT2ACYP1B1ABCB1MEN1CYP3A4 | |
| Apigenin SCHEMBL29872582 | 0.98 | KMT2A (0.97) | KMT2ACYP1B1ABCB1MEN1CYP3A4 | |
| Apigenin SCHEMBL29458838 | 0.98 | KMT2A (0.97) | KMT2ACYP1B1ABCB1MEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106404955-A | Method for measuring content of quercetin-7-glucoside in sorghum red pigment | 长治市食品药品检验所 | 2017-02-15 | — | — | CN | disclosed |
| CN-104066840-B | Novel glycosyltransferase gene and use thereof | 三得利控股株式会社 | 2016-11-09 | — | — | CN | disclosed |
| CN-102596170-B | Compositions and methods for enhancing eyelashes | AVON PROD INC | 2014-07-30 | — | — | CN | disclosed |
| US-20080070971-A1 | Medical Use of Bilirubin and its Structural Analogues | WANG XIANG H | 2008-03-20 | — | — | US | disclosed |
| EP-1776161-A1 | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE UDP GLUCURONOSYL TRANSFERASE (UGT) ENZYMES INDUCER | Sederma S.A.S. (FR) | 2007-04-25 | — | — | EP | disclosed |
| US-20050271755-A1 | Phytomedicinal compositions for the control of lipid accumulation and metabolism in mammals | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2005-12-08 | — | — | US | disclosed |
| WO-2005112963-A2 | PHYTOMEDICINAL COMPOSITIONS FOR THE CONTROL OF LIPID ACCUMULATION AND METABOLISM IN MAMMALS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2005-12-01 | — | — | WO | disclosed |
| WO-2005102266-A1 | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE UDP GLUCURONOSYL TRANSFERASE (UGT) ENZYMES INDUCER | SEDERMA, SAS (FR) | 2005-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080070971-A1 | Medical Use of Bilirubin and its Structural Analogues | RBP1, RBP4, AGER | KMT2A 4282/4885CYP1B1 62/4885ABCB1 494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.